Apellis Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 63.3 | 141.3 | 38.0 | |
| – | – | – | – | – | – | 64,343.3 | 96,415.1 | 104,247.4 | 86,672.8 | 66,213.9 | 97,815.9 | 138,674.3 | 133,117.9 | – | – | – | 4,531.7 | 18.1 | 13.6 | 20.3 | 11.0 | 60.9 | 61.5 | 49.9 | 65.9 | 75.8 | 71.0 | 58.9 | 16.8 | 18.3 | 13.8 | 7.6 | 5.0 | 5.1 | 3.5 | 2.9 | 2.8 | 3.2 | 4.6 | |
| – | – | – | – | – | – | 5.0 | 8.6 | 5.2 | 5.1 | 4.7 | 5.0 | 10.1 | 11.0 | 65.9 | 7.6 | 10.6 | 21.6 | 22.2 | 65.8 | – | – | 20.4 | 10.8 | 14.4 | 24.2 | 33.7 | 18.2 | 31.5 | 19.7 | 37.3 | 27.1 | 18.0 | 15.0 | 17.3 | 16.7 | 13.9 | 7.1 | 8.5 | 12.2 | |
| – | – | – | – | – | – | 53,698.5 | 87,777.2 | 86,892.0 | 69,887.7 | 53,285.1 | 73,518.1 | 114,338.4 | 107,899.1 | – | – | – | 4,415.9 | 17.3 | 14.1 | 20.8 | 10.7 | 54.2 | 56.1 | 45.6 | 61.6 | 69.8 | 64.7 | 56.1 | 15.5 | 17.7 | 13.5 | 7.7 | 5.1 | 5.1 | 3.7 | 3.0 | 2.8 | 3.1 | 4.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 30.3 | 45.1 | 28.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 493.9 | 36.2 | 69.8 | 134.1 | |
| – | – | – | – | – | – | -6.3% | -5.5% | -6.7% | -10.2% | -17.2% | -12.8% | -9.6% | -11.4% | -9.4% | -14.4% | -13.8% | -17.0% | -3.7% | -6.2% | -4.8% | -11.0% | -13.9% | -10.5% | -10.4% | -6.5% | -9.0% | -7.7% | -5.7% | -14.0% | -8.2% | -7.6% | -8.6% | -5.8% | -2.2% | -0.3% | 0.2% | 2.8% | 1.4% | 0.7% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | -100,307.2% | -286,046.2% | -576,160.6% | -785,968.3% | -785,968.3% | -1,021,742.0% | -1,281,584.3% | -1,577,399.6% | – | – | – | 33.0% | 99.8% | 99.7% | 41.6% | 42.7% | -120.7% | -82.5% | 98.0% | 97.2% | 92.5% | 88.5% | 88.9% | 84.8% | 85.2% | 86.4% | 86.2% | 86.3% | 84.8% | 82.9% | 83.7% | 88.8% | 89.8% | 90.1% | |
| – | – | – | – | – | – | -439,837.1% | -547,149.5% | -732,152.1% | -941,959.8% | -1,108,343.4% | -1,344,117.1% | -1,603,959.5% | -1,899,774.7% | – | – | – | -89,243.3% | -85.3% | -95.6% | -126.7% | -123.6% | -805.7% | -668.0% | -512.2% | -459.9% | -788.4% | -605.1% | -331.9% | -218.7% | -130.4% | -77.1% | -49.8% | -31.2% | -21.1% | -24.0% | -25.2% | 7.9% | 5.5% | 14.9% | |
| – | – | – | – | – | – | -441,916.5% | -551,819.4% | -735,565.8% | -946,958.9% | -1,104,669.9% | -1,354,522.6% | -1,681,641.0% | -1,974,943.7% | – | – | – | -106,419.9% | -137.6% | -143.5% | -183.2% | -203.0% | -1,121.3% | -866.8% | -660.6% | -560.9% | -864.7% | -652.6% | -356.1% | -222.1% | -133.3% | -79.6% | -52.9% | -35.0% | -25.3% | -28.8% | -30.2% | 4.4% | 2.2% | 12.1% | |
| – | – | – | – | – | – | -403,700.2% | -529,400.2% | -695,726.9% | -886,288.1% | -1,137,071.5% | -1,254,038.7% | -1,335,507.6% | -1,516,890.7% | – | – | – | -77,263.0% | -66.2% | -84.2% | -97.5% | -121.1% | -847.7% | -645.0% | -517.9% | -430.1% | -683.2% | -549.2% | -338.5% | -234.2% | -150.2% | -105.1% | -65.0% | -28.7% | -11.3% | -1.1% | 0.6% | 7.7% | 4.5% | 3.4% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | -114.0% | -124.1% | -145.8% | -322.6% | -34.2% | -49.4% | -37.0% | -55.8% | -79.2% | -69.6% | -122.0% | -163.3% | -890.2% | -163.3% | -202.7% | -506.8% | -168.6% | -696.3% | – | – | -375.7% | -151.8% | -190.9% | -206.3% | -383.9% | -167.7% | -190.2% | -260.9% | -271.8% | -156.5% | -125.9% | -105.5% | -86.6% | -136.2% | -146.0% | 11.2% | 6.0% | 32.1% | |
| – | – | -98.9% | -312.7% | -61.8% | -205.7% | -28.0% | -39.0% | -31.8% | -45.7% | -62.6% | -49.1% | -61.3% | -48.9% | -78.3% | -61.4% | -54.1% | -69.8% | -35.9% | -44.4% | -65.8% | -98.9% | -84.6% | -61.2% | -63.7% | -72.6% | -85.8% | -70.6% | -71.8% | -74.1% | -67.0% | -50.2% | -36.8% | -27.7% | -22.4% | -27.7% | -27.8% | 4.2% | 2.1% | 12.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | -123 | -100 | -200 | -194 | -149 | -280 | -281 | -291 | -207 | -271 | 34 | -58 | -203 | 125 | 120 | -90 | -447 | -440 | -410 | -486 | -453 | -666 | -518 | -354 | -252 | -144 | 103 | 62 | 48 | 102 | 90 | -17 | -5.3 | 56 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.2 | -0.1 | 0.3 | |
| – | – | 86.7% | 251.9% | 42.3% | 63.8% | 81.8% | 79.1% | 86.0% | 81.9% | 79.1% | 70.6% | 50.2% | 29.9% | 8.8% | 37.6% | 26.7% | 13.8% | 21.3% | 6.4% | -20.2% | -10.9% | 22.5% | 40.3% | 33.4% | 35.2% | 22.3% | 42.1% | 37.7% | 28.4% | 24.7% | 32.1% | 29.2% | 26.3% | 25.8% | 20.3% | 19.0% | 37.9% | 34.4% | 38.3% | |
| – | – | – | – | – | – | 0.4 | 0.4 | 0.2 | 0.1 | 0.2 | 0.0 | 0.1 | 1.0 | 4.2 | 0.6 | 1.5 | 3.4 | 1.8 | 7.6 | – | – | 1.0 | 0.4 | 0.6 | 0.3 | 0.6 | 0.2 | 0.3 | 0.4 | 0.5 | 0.7 | 1.8 | 1.9 | 2.0 | 2.8 | 3.0 | 1.2 | 1.2 | 1.1 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -2.91 | -1.59 | -1.50 | -1.63 | -1.93 | -1.15 | -1.49 | -1.26 | -1.55 | -1.94 | -2.20 | -2.70 | -3.07 | -3.58 | -4.13 | -5.74 | -6.23 | -7.09 | -4.35 | -4.54 | -5.71 | -6.07 | -8.71 | -7.15 | -5.99 | -5.81 | -5.90 | -6.07 | -5.51 | -5.04 | -4.36 | -3.39 | -2.69 | -2.02 | -1.60 | -1.78 | -1.81 | 0.36 | 0.18 | 1.06 | |
| – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 3.16 | 3.16 | 3.12 | 2.99 | 0.78 | 0.83 | 0.91 | 1.04 | 0.68 | 0.93 | 1.55 | 2.27 | 3.27 | 4.26 | 5.07 | 5.77 | 6.31 | 6.18 | 5.99 | 8.07 | 7.97 | 8.77 | |
| – | – | 1.32 | 1.32 | 1.33 | 0.36 | 4.35 | 2.56 | 4.20 | 3.49 | 2.78 | 3.88 | 2.51 | 2.19 | 0.46 | 3.51 | 3.07 | 1.40 | 2.58 | 0.65 | -1.75 | -0.67 | 2.32 | 4.71 | 3.14 | 2.82 | 1.54 | 3.62 | 2.89 | 1.93 | 1.60 | 2.17 | 2.13 | 1.91 | 1.84 | 1.31 | 1.24 | 3.18 | 2.94 | 3.29 | |
| -1.31 | -1.46 | -1.44 | -1.55 | -1.82 | -1.10 | -1.36 | -1.21 | -1.47 | -1.82 | -2.27 | -2.50 | -2.44 | -2.75 | -2.89 | -3.87 | -4.50 | -5.15 | -2.09 | -2.66 | -3.04 | -3.62 | -6.59 | -5.32 | -4.69 | -4.46 | -4.66 | -5.11 | -5.23 | -5.31 | -4.91 | -4.48 | -3.30 | -1.66 | -0.71 | -0.07 | 0.04 | 0.62 | 0.36 | 0.30 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.